Matthew Meyer

Matthew, is an experienced life science executive and corporate attorney who has held diverse roles across a wide range of private and public biopharma, MedTech, and precision medicine companies from start-ups to Fortune 50 in the U.S. and Europe. Matthew has led, structured and negotiated dozens of life science business development, joint venture and licensing transactions and has been instrumental in raising over $250 million for life science companies.

5 Tips from Venture Capitalists on Raising Capital for Your Biotech Startup

Research and development are vital for any biotech startup, however, raising venture capital (VC) can be a challenge…

Scroll to Top